Shenzhen Mindray Bio-Medical Electronics

300760 · SZSE · CNY

¥161.32Change from previous close: +1.45%Absolute change: +¥2.31

Close · September 30, 2026

At a glance

Revenue growth
−9.38%
2025 vs 2024
Net income growth
−30.28%
2025 vs 2024
Net margin
24.4%
2024: 31.8%

Financial data

Amounts in millions of CNY; per-share values in CNY; shares in millions.

Income statement · Annual
Item2025202420232022
Total revenue33,28236,72634,93230,366
Cost of revenue13,20813,54812,51310,885
Gross profit20,07423,17822,41919,480
Selling, general and administrative1,8011,7222,2842,031
Research and development3,5793,6663,4332,923
Operating income9,93813,05012,91710,668
EBIT9,69813,03913,02410,964
EBITDA11,41914,50814,03411,849
Interest expense24.019.413.010.7
Pre-tax income9,67413,02013,01110,954
Income tax1,2221,2801,4331,343
Net income8,13611,66811,5829,607
Net income to common shareholders8,13611,66811,5829,607
Basic EPS6.719.649.567.94
Diluted EPS6.719.639.567.94
Average shares (basic)1,2121,2111,2121,210
Average shares (diluted)1,2121,2111,2121,210